JWCA
IBB icon

J.W. Cole Advisors’s iShares Biotechnology ETF IBB Stock Holding History

J.W. Cole Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518K Buy
+2,722
New +$468K 0.01% 993
2026
Q1 		– Sell
-3,707
Closed -$550K – 1079
2025
Q4 		$550K Sell
3,707
-202
-5% -$32.8K 0.01% 858
2025
Q3 		$564K Sell
3,909
-714
-15% -$97.5K 0.01% 947
2025
Q2 		$585K Sell
4,623
-119
-3% -$14.6K 0.01% 864
2025
Q1 		$607K Buy
4,742
+1,641
+53% +$223K 0.02% 709
2024
Q4 		$410K Sell
3,101
-173
-5% -$24.3K 0.02% 674
2024
Q3 		$477K Buy
3,274
+31
+1% +$4.49K 0.02% 612
2024
Q2 		$445K Sell
3,243
-2,902
-47% -$387K 0.02% 551
2024
Q1 		$843K Sell
6,145
-441
-7% -$60.2K 0.04% 378
2023
Q4 		$895K Sell
6,586
-220
-3% -$26.8K 0.05% 324
2023
Q3 		$832K Sell
6,806
-101
-1% -$12.8K 0.06% 291
2023
Q2 		$877K Sell
6,907
-38
-0.5% -$4.94K 0.06% 292
2023
Q1 		$897K Buy
6,945
+675
+11% +$88.4K 0.06% 311
2022
Q4 		$823K Sell
6,270
-2,114
-25% -$273K 0.06% 307
2022
Q3 		$981K Sell
8,384
-411
-5% -$51K 0.08% 256
2022
Q2 		$1.03M Buy
8,795
+1,600
+22% +$190K 0.08% 257
2022
Q1 		$937K Buy
7,195
+180
+3% +$23.4K 0.06% 294
2021
Q4 		$1.07M Buy
+7,015
New +$1.09M 0.07% 284
2021
Q3 		– Sell
-7,839
Closed -$1.28M – 569
2021
Q2 		$1.28M Buy
7,839
+1,342
+21% +$207K 0.1% 227
2021
Q1 		$978K Sell
6,497
-2,243
-26% -$356K 0.09% 240
2020
Q4 		$1.32M Sell
8,740
-3,373
-28% -$482K 0.14% 183
2020
Q3 		$1.64M Buy
12,113
+566
+5% +$76.8K 0.13% 177
2020
Q2 		$1.58M Buy
+11,547
New +$1.47M 0.24% 119
2020
Q1 		– Sell
-6,051
Closed -$729K – 279
2019
Q4 		$729K Buy
+6,051
New +$675K 0.09% 232

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return

J.W. Cole Advisors's IBB Position: Q2 2026 in Review

J.W. Cole Advisors opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 2,722 shares worth $518K. The stake represents 0.01% of the portfolio and ranks #993 among its holdings. This is a return to the name: J.W. Cole Advisors previously reported a position in IBB as recently as Q4 2025.

J.W. Cole Advisors first reported a position in IBB in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.64M in Q3 2020. 378 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • J.W. Cole Advisors held 2,722 shares of iShares Biotechnology ETF worth $518K as of Q2 2026.
  • iShares Biotechnology ETF was a new J.W. Cole Advisors position in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #993 holding.
  • J.W. Cole Advisors first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 24 quarters since.
  • J.W. Cole Advisors's iShares Biotechnology ETF position peaked at $1.64M in Q3 2020.
  • 378 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.